• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

What is the Time Frame for a Stroke following a TIA?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Transient ischemic attack (TIA) is a strong predictor of impending stroke, allowing for management and preventative interventions
  • Lioutas et al. (JAMA, 2021) examined population-based incidence of TIA and the timing and long-term trends of stroke risk following TIA

METHODS:

  • Retrospective cohort study
  • Data source
    • Framingham Heart Study (a prospective cohort study)
  • Participants
    • Individuals with no history of TIA or stroke at baseline
    • Followed up from 1948 to December 31, 2017
  • Exposures
    • Calendar time: TIA incidence calculation, time-trends analyses
    • TIA: Matched longitudinal cohort
  • Study design
    • TIA-free participants were matched 5:1 to participants with first incidence TIA on age and sex
  • Primary outcomes
    • TIA incidence rates
    • Proportion of stroke occurring after TIA in the short term (7, 30, and 90 days) vs the long term (>1 to10 years)
    • Stroke after TIA vs stroke among matched control participants without TIA
    • Time trends of stroke risk at 90 days after TIA assessed in 3 epochs: 1954 to 1985 | 1986 to 1999 | 2000 to 2017

RESULTS:

  • 14,059 participants | 66 years of follow-up | 366,209 person-years
    • Experienced TIA: 435 participants
      • 53% women; mean age 73.47 years
      • 47% men; mean age 70.10 years
    • Control: 2175 participants
  • Estimated incidence rate of TIA: 1.19/1000 person-years
  • After TIA, 29.5% of participants had a stroke (median 8.86 years of follow-up)
  • Time to stroke after TIA
    • Within 7 days: 21.5%
    • Within 30 days: 30.8%
    • Within 90 days: 39.2%
    • >1 year after the index TIA: 48.5%
    • Median time to stroke was 1.64 (IQR 0.07 to 6.6) years
  • The age- and sex-adjusted cumulative 10-year hazard of incident stroke
    • With TIA: Hazard ratio (HR) 0.46 (95% CI, 0.39 to 0.55)
    • Without TIA: HR 0.09 (95% CI, 0.08 to 0.11)
  • Fully adjusted HR 4.37 (95% CI, 3.30 to 5.71; P < 0.001)
  • 90-day risk of stroke after TIA by time epoch
    • Risk in 1948 to 1985: 16.7% (26 stokes in 155 TIA patients)
    • Risk in 1986 to 1999: 11.1% (18 strokes in 162 patients)
    • Risk in 2000 to 2017: 5.9% (7 strokes in 118 patients)
  • Compared with the first epoch, the HR for 90-day risk of stroke has been declining (P = 0.005 for trend)
    • Second epoch: 0.60 (95% CI, 0.33 to 1.12)
    • Third epoch: 0.32 (95% CI, 0.14 to 0.75)

CONCLUSION:

  • Risk of stroke was significantly increased after TIA even after accounting for confounding cardiovascular risk factors
    • Patients with TIA require “vigorous surveillance beyond the early, high-risk period and with special attention to hypertension monitoring and treatment”
  • The risk of stroke following TIA is decreasing over time, even though the population is aging
  • The authors state

1- and 5-year risks of post TIA stroke in the 2000-2017 era are 7.6% and 16.1%, respectively, considerably lower than the respective cumulative risks over the entire observation period and closer to modern era estimates

These decreases most likely reflect the effectiveness of secondary prevention interventions such as stricter blood pressure control and administration of antithrombotic medications

Learn More – Primary Sources:

Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke

Now You Can Get Mobile-Friendly ObG Clinical Research Summaries with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Does a Mediterranean Diet with Extra Olive Oil Decrease Risk of Gestational Diabetes Mellitus?
The VIRGO Study Results: In Younger Individuals, Does Heart Attack Presentation Differ Between Women and Men?
Do Artificially Sweetened Drinks Increase Risk for Stroke?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site